Physician profile
Todd Miller
NPI 1033387931
$258,958.66
in general payments reported to CMS, 2019-2025
24 companies · $18K in 2025
The $18K reported for 2025 was more than what 98% of Otolaryngology providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,633 · 2020: $1,629 · 2021: $35K · 2022: $77K · 2023: $92K · 2024: $30K · 2025: $18K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $74K · Grant: $62K · Food and Beverage: $2,624 · Consulting Fee: $1,425 · Education: $34.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $74,068.95 |
| Grant | $62,030.00 |
| Food and Beverage | $2,623.74 |
| Consulting Fee | $1,425.00 |
| Education | $34.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $136,158.55 | 2023-2025 | |
| Allergan, INC. | $106,417.72 | 2019-2022 | |
| Merz North America, INC. | $6,771.69 | 2019-2022 | |
| Stryker Corporation | $3,647.06 | 2019-2022 | |
| Inspire Medical Systems, INC. | $3,431.57 | 2019-2025 | Inspire |
| Genzyme Corporation | $624.05 | 2022-2025 | |
| Glaxosmithkline, LLC. | $470.74 | 2021-2025 | Nucala |
| Regeneron Healthcare Solutions, INC. | $389.30 | 2021-2025 | Dupixent |
| Intersect Ent, INC. | $369.35 | 2019-2021 | |
| Optinose US, INC. | $158.86 | 2019-2025 | |
| Janssen Pharmaceuticals, INC | $63.74 | 2019 | |
| Acclarent, INC | $63.24 | 2019-2023 | Relieva Spinplus, Acclarent Aera |
| Amgen INC. | $62.21 | 2025 | Tezspire |
| Medtronic, INC. | $48.39 | 2021 | |
| Aerin Medical INC. | $45.34 | 2024-2025 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $43.75 | 2019 | |
| Integra Lifesciences Corporation | $40.74 | 2025 | Trudi Probe, Relieva Spinplus Nav, Inspira Air |
| Hikma Pharmaceuticals USA | $34.14 | 2023-2025 | Ryaltris |
| Smith+Nephew, INC. | $24.11 | 2024 | |
| Boston Scientific Corporation | $24.10 | 2019 | |
| Jazz Pharmaceuticals INC. | $23.77 | 2023 | |
| Arbor Pharmaceuticals, INC. | $19.60 | 2019 | |
| Glenmark Therapeutics INC. | $14.00 | 2019 | |
| Phathom Pharmaceuticals, INC. | $12.64 | 2025 | Voquezna |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Todd Miller listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.